Factors affecting SARS-CoV-2 (COVID-19) Pandemic, including Zoonotic, Human Transmission and Chain of Infection. Reducing Public health Risk by Serum Antibody Testing, Avoiding Screening in Unhygienic Places and False PCR Reporting. A Scientific Review
During December 2019, a rapid increase in the number of SARS-CoV-2 (COVID-19) cases was reported worldwide. We investigated several factors for rapid increase in SARS-COV-2. Genomic sequence reveals that domestic and wild animals were likely ancestors and zoonotic source for SARS-CoVs, MERS-CoVs, an...
| Main Authors: | , , , |
|---|---|
| Format: | Text |
| Language: | English |
| Published: |
Zenodo
2021
|
| Subjects: | |
| Online Access: | https://dx.doi.org/10.5281/zenodo.4599717 https://zenodo.org/record/4599717 |
| Summary: | During December 2019, a rapid increase in the number of SARS-CoV-2 (COVID-19) cases was reported worldwide. We investigated several factors for rapid increase in SARS-COV-2. Genomic sequence reveals that domestic and wild animals were likely ancestors and zoonotic source for SARS-CoVs, MERS-CoVs, and SARS-CoV-2; these viruses replicated in animals and humans during past several decades, exhibiting diverse mutations and self-limiting diseases except during outbreaks. SARS-CoV-2 has been retrospectively isolated in different studies in August 2019, several months before Wuhan reported. Hence, there is a possibility that viruses went undetected and infecting sub-clinically, in past several years, and SARS-CoV-2 antigens and neutralizing antibodies may have been present in humans since years. All SARS-CoVs are basically respiratory viruses, spread by droplets, hence droplet precautions are essential. Furthermore, silent phase of transmission (asymptomatic/subclinical) can be beneficial for humans. Lack of symptoms eventually lessen virus transmission and reduce the pathogen's long-term survival and provide strong humoral herd immunity (with sropositivity and diverse antibodies) up to several years and during epidemics. RT-PCR has low sensitivity and specificity, carries a high risk of handling live virus antigens, and requires difficult protocols. As viral load also sharply declines after few days of onset of infection, this technique might overlook infection. Furthermore, SARS-CoV-2 infection may be present in blood when oropharyngeal swabs are negative by RT-PCR. Conversely, antibodies against SARS-CoVs develop robustly in by reduced amount of antigens and ELISA for diagnosing antibodies demonstrates 100% specificity and 100% sensitivity, even in clinically asymptomatic individuals. These antibodies can be used for serologic surveys, monitoring and screening. Furthermore, screening tests for SARS-COV-2 should be avoided in unhygienic public places by nasopharyngeal swabs, which carry a high risk of further transmission, co-infection or super-infection. If above mentioned factors and Infection control policy is followed, SARS-CoV-2 pandemic can be controlled effectively. : {"references": ["Ambali AG, Jones RC. Early pathogenesis in chicks of infection with an enterotropic strain of infectious bronchitis virus. Avian Dis. 1990;34(4):809-17.", "Cavanagh D. Coronaviruses in poultry and other birds. Avian Pathol. 2005;34(6):439-48. doi: 10.1080/03079450500367682.", "Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368(6494):1016-20. doi: 10.1126/science.abb7015.", "Poon LL, Chu DK, Chan KH, Wong OK, Ellis TM, Leung YH, et al. Identification of a novel coronavirus in bats. J Virol. 2005;79(4):2001-9. doi: 10.1128/JVI.79.4.2001-2009.2005.", "Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676-9. doi: 10.1126/science.1118391.", "Woo PC, Lau SK, Li KS, Poon RW, Wong BH, Tsoi HW, et al. Molecular diversity of coronaviruses in bats. Virology. 2006;351(1):180-7. doi: 10.1016/j.virol.2006.02.041.", "Mihindukulasuriya KA, Wu G, St Leger J, Nordhausen RW, Wang D. Identification of a novel coronavirus from a beluga whale by using a panviral microarray. J Virol. 2008;82(10):5084-8. doi: 10.1128/JVI.02722-07.", "Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966;121(1):190-3. doi: 10.3181/00379727-121-30734.", "Almeida JD, Tyrrell DA. The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol. 1967;1(2):175-8. doi: 10.1099/0022-1317-1-2-175.", "Bradburne AF, Bynoe ML, Tyrrell DA. Effects of a \"new\" human respiratory virus in volunteers. Br Med J. 1967;3(5568):767-9. doi: 10.1136/bmj.3.5568.767.", "McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A. 1967;57(4):933-40. doi: 10.1073/pnas.57.4.933.", "Burks JS, DeVald BL, Jankovsky LD, Gerdes JC. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 1980;209(4459):933-4. doi: 10.1126/science.7403860.", "Murray RS, Brown B, Brian D, Cabirac GF. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol. 1992;31(5):525-33. doi: 10.1002/ana.410310511.", "Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992;191(1):502-5. doi: 10.1016/0042-6822(92)90220-j.", "Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by human respiratory coronaviruses. J Virol. 2000;74(19):8913-21. doi: 10.1128/jvi.74.19.8913-8921.2000.", "Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathol. 2001;101(6):601-4. doi: 10.1007/s004010000331.", "Gilden DH. Infectious causes of multiple sclerosis. Lancet Neurol. 2005;4(3):195-202. doi: 10.1016/S1474-4422(05)01017-3.", "Hansen GH, Delmas B, Besnardeau L, Vogel LK, Laude H, Sj\u00f6str\u00f6m H, et al. The coronavirus transmissible gastroenteritis virus causes infection after receptor-mediated endocytosis and acid-dependent fusion with an intracellular compartment. J Virol. 1998;72(1):527-34. doi: 10.1128/JVI.72.1.527-534.1998.", "Perlman S. Pathogenesis of coronavirus-induced infections. Review of pathological and immunological aspects. Adv Exp Med Biol. 1998;440:503-13.", "Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005;69(4):635-64. doi: 10.1128/MMBR.69.4.635-664.2005.", "He B, Zhang Y, Xu L, Yang W, Yang F, Feng Y, et al. Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. J Virol. 2014;88(12):7070-82. doi: 10.1128/JVI.00631-14.", "Shi Z, Hu Z. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 2008;133(1):74-87. doi: 10.1016/j.virusres.2007.03.012.", "Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci U S A. 2005;102(39):14040-5. doi: 10.1073/pnas.0506735102.", "Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017.", "WHO. Coronavirus disease 2019. Available from: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019 (accessed May 2020).", "Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536-44. doi: 10.1038/s41564-020-0695-z.", "Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12(2):135. doi: 10.3390/v12020135.", "Lauber C, Gorbalenya AE. Partitioning the genetic diversity of a virus family: approach and evaluation through a case study of picornaviruses. J Virol. 2012;86(7):3890-904. doi: 10.1128/JVI.07173-11.", "King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier; 2011.", "B\u00e1rcena M, Oostergetel GT, Bartelink W, Faas FG, Verkleij A, Rottier PJ, et al. Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A. 2009;106(2):582-7. doi: 10.1073/pnas.0805270106.", "Neuman BW, Adair BD, Yoshioka C, Quispe JD, Orca G, Kuhn P, et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol. 2006;80(16):7918-28. doi: 10.1128/JVI.00645-06.", "Maier HJ, Bickerton E, Britton P. Coronaviruses: methods and protocols. Springer; 2015.", "Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A. 2009;106(14):5871-6. doi: 10.1073/pnas.0809524106.", "Kubo H, Yamada YK, Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol. 1994;68(9):5403-10. doi: 10.1128/JVI.68.9.5403-5410.1994.", "Zeng F, Chow KY, Leung FC. Estimated timing of the last common ancestor of the SARS coronavirus. N Engl J Med. 2003;349(25):2469-70. doi: 10.1056/NEJM200312183492523.", "Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281-92.e6. doi: 10.1016/j.cell.2020.02.058.", "Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5(4):562-9. doi: 10.1038/s41564-020-0688-y.", "Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260-3. doi: 10.1126/science.abb2507.", "Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-36. doi: 10.1080/22221751.2020.1719902.", "Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. doi: 10.1038/s41586-020-2012-7.", "Zhang Z, Wu Q, Zhang T. Pangolin homology associated with 2019-nCoV. bioRxiv. 2020. doi: 10.1101/2020.02.19.950253.", "Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181-92. doi: 10.1038/s41579-018-0118-9.", "Fischer H, Tschachler E, Eckhart L. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection. Front Immunol. 2020;11:939. doi: 10.3389/fimmu.2020.00939.", "Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94(7):e00127-20. doi: 10.1128/JVI.00127-20.", "Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020;71(15):778-85. doi: 10.1093/cid/ciaa310.", "Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-9. doi: 10.1038/s41586-020-2008-3.", "Hu D, Zhu C, Ai L, He T, Wang Y, Ye F, et al. Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats. Emerg Microbes Infect. 2018;7(1):154. doi: 10.1038/s41426-018-0155-5.", "McIntosh K, Becker WB, Chanock RM. Growth in suckling-mouse brain of \"IBV-like\" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A. 1967;58(6):2268-73. doi: 10.1073/pnas.58.6.2268.", "G\u00e1mbaro F, Behillil S, Baidaliuk A, Donati F, Albert M, Alexandru A, et al. Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020. Euro Surveill. 2020;25(26):2001200. doi: 10.2807/1560-7917.ES.2020.25.26.2001200.", "Deslandes A, Berti V, Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, et al. SARS-CoV-2 was already spreading in France in late December 2019. Int J Antimicrob Agents. 2020;55(6):106006. doi: 10.1016/j.ijantimicag.2020.106006.", "GISAID. Available from: https://www.gisaid.org/ (accessed May 2020).", "Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6(7):e1001005. doi: 10.1371/journal.ppat.1001005.", "Domingo E, Baranowski E, Ruiz-Jarabo CM, Mart\u00edn-Hern\u00e1ndez AM, S\u00e1iz JC, Escarm\u00eds C. Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis. 1998;4(4):521-7. doi: 10.3201/eid0404.980402.", "Domingo E, Martin V, Perales C, Grande-P\u00e9rez A, Garc\u00eda-Arriaza J, Arias A. Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol. 2006;299:51-82. doi: 10.1007/3-540-26397-7_3.", "Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet. 2008;9(4):267-76. doi: 10.1038/nrg2323.", "Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science. 1982;215(4540):1577-85. doi: 10.1126/science.7041255.", "Batschelet E, Domingo E, Weissmann C. The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate. Gene. 1976;1(1):27-32. doi: 10.1016/0378-1119(76)90004-4.", "Steinhauer DA, Holland JJ. Rapid evolution of RNA viruses. Annu Rev Microbiol. 1987;41:409-33. doi: 10.1146/annurev.mi.41.100187.002205.", "Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(15):713-20. doi: 10.1093/cid/ciaa203.", "Goldmann DA. Transmission of viral respiratory infections in the home. Pediatr Infect Dis J. 2000;19(10 Suppl):S97-102. doi: 10.1097/00006454-200010001-00002.", "Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020;81:104260. doi: 10.1016/j.meegid.2020.104260.", "Ni M, Chen C, Qian J, Xiao HX, Shi WF, Luo Y, et al. Intra-host dynamics of Ebola virus during 2014. Nat Microbiol. 2016;1(11):16151. doi: 10.1038/nmicrobiol.2016.151.", "Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang YP, et al. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol. 2004;4:21. doi: 10.1186/1471-2148-4-21.", "Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, et al. The Genome sequence of the SARS-associated coronavirus. Science. 2003 30;300(5624):1399-404. doi: 10.1126/science.1085953.", "Braun MJ, Clements JE, Gonda MA. The visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins. J Virol. 1987;61(12):4046-54. doi: 10.1128/JVI.61.12.4046-4054.1987.", "Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004;303(5664):1666-9. doi: 10.1126/science.1092002.", "Brown EG, Tetro JA. Comparative analysis of the SARS coronavirus genome: a good start to a long journey. Lancet. 2003;361(9371):1756-7. doi: 10.1016/S0140-6736(03)13444-7.", "Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382(9):872-4. doi: 10.1056/NEJMc2001272.", "Zumla A, Hui DS. Infection control and MERS-CoV in health-care workers. Lancet. 2014;383(9932):1869-71. doi: 10.1016/S0140-6736(14)60852-7.", "WHO. WHO statement on the Fifth Meeting of the IHR Emergency Committee concerning MERS-CoV. May 14, 2014. Available from: https://www.who.int/mediacentre/news/statements/2014/mers-20140514/en/ (accessed May 2020).", "Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections. J Hosp Infect. 2000;46(1):55-60. doi: 10.1053/jhin.2000.0795.", "Falsey AR, McCann RM, Hall WJ, Criddle MM, Formica MA, Wycoff D, et al. The \"common cold\" in frail older persons: impact of rhinovirus and coronavirus in a senior daycare center. J Am Geriatr Soc. 1997;45(6):706-11. doi: 10.1111/j.1532-5415.1997.tb01474.x.", "Seto WH, Conly JM, Pessoa-Silva CL, Malik M, Eremin S. Infection prevention and control measures for acute respiratory infections in healthcare settings: an update. East Mediterr Health J. 2013;19 Suppl 1:S39-47.", "Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill. 2013;18(11):20427. doi: 10.2807/ese.18.11.20427-en.", "Pebody RG, Chand MA, Thomas HL, Green HK, Boddington NL, Carvalho C, et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill. 2012;17(40):20292.", "Buchholz U, M\u00fcller MA, Nitsche A, Sanewski A, Wevering N, Bauer-Balci T, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18(8):20406.", "Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis. 1982;146(1):47-51. doi: 10.1093/infdis/146.1.47.", "Ryan MA, Christian RS, Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med. 2001;21(2):79-83. doi: 10.1016/s0749-3797(01)00323-3.", "van Dorp L, Richard D, Tan CCS, Shaw LP, Acman M, Balloux F. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020;11(1):5986. doi: 10.1038/s41467-020-19818-2.", "Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis. 2000;181(1):344-8. doi: 10.1086/315213.", "Evans ME, Hall KL, Berry SE. Influenza control in acute care hospitals. Am J Infect Control. 1997;25(4):357-62. doi: 10.1016/s0196-6553(97)90029-8.", "Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2000;21(7):449-54. doi: 10.1086/501786.", "Sugaya N, Kusumoto N, Suzuki Y, Nerome R, Nerome K. Large sequential outbreaks caused by influenza A (H3N2) and B viruses in an institution for the mentally handicapped. J Med Virol. 1996;50(2):120-5. doi: 10.1002/(SICI)1096-9071(199610)50:2<120::AID-JMV4>3.0.CO;2-C.", "Bean B, Rhame FS, Hughes RS, Weiler MD, Peterson LR, Gerding DN. Influenza B: hospital activity during a community epidemic. Diagn Microbiol Infect Dis. 1983;1(3):177-83. doi: 10.1016/0732-8893(83)90016-0.", "Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020;323(8):707-8. doi: 10.1001/jama.2020.0757.", "Hall CB. The spread of influenza and other respiratory viruses: complexities and conjectures. Clin Infect Dis. 2007;45(3):353-9. doi: 10.1086/519433.", "Langmuir AD. Changing concepts of airborne infection of acute contagious diseases: a reconsideration of classic epidemiologic theories. Ann N Y Acad Sci. 1980;353:35-44. doi: 10.1111/j.1749-6632.1980.tb18903.x.", "van den Brand JM, Smits SL, Haagmans BL. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol. 2015;235(2):175-84. doi: 10.1002/path.4458.", "Burke JP. Infection control - a problem for patient safety. N Engl J Med. 2003;348(7):651-6. doi: 10.1056/NEJMhpr020557.", "Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24(8):1634-43. doi: 10.1038/sj.emboj.7600640.", "Qu XX, Hao P, Song XJ, Jiang SM, Liu YX, Wang PG, et al. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J Biol Chem. 2005;280(33):29588-95. doi: 10.1074/jbc.M500662200.", "Bell DM; World Health Organization Working Group on International and Community Transmission of SARS. Public health interventions and SARS spread, 2003. Emerg Infect Dis. 2004;10(11):1900-6. doi: 10.3201/eid1011.040729.", "Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A. 2004;101(16):6146-51. doi: 10.1073/pnas.0307506101.", "Mumford JD. Environmental risk evaluation in quarantine decision making. In: Anderson K, McRae C, Wilson D. The economics of quarantine and the SPS agreement. University of Adelaide Press; 2001:353-84.", "Breukers A, Mourits M, van der Werf W, Lansink AO. Costs and benefits of controlling quarantine diseases: a bio\u2010economic modeling approach. Agric Econ. 2008;38(2):137-49. doi: 10.1111/j.1574-0862.2008.00288.x.", "Mumford JD. Economic issues related to quarantine in international trade. Eur Rev Agric Econ. 2002;29(3):329-48.", "James S, Anderson K. On the need for more economic assessment of quarantine policies. Aust J Agric Resour Econ. 1998;42(4):425-44. doi: 10.22004/ag.econ.117286.", "Leung GM, Chung PH, Tsang T, Lim W, Chan SK, Chau P, et al. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004;10(9):1653-6. doi: 10.3201/eid1009.040155.", "Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003;300(5627):1961-6. doi: 10.1126/science.1086478.", "Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276-8. doi: 10.1126/science.1087139.", "Centers for Disease Control and Prevention (CDC). Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52(41):986-7.", "Yu IT, Li Y, Wong TW, Tam W, Chan AT, Lee JH, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004;350(17):1731-9. doi: 10.1056/NEJMoa032867.", |
|---|